Erschienen in:
20.01.2022 | Editorial
Anticoagulation Resumption After Colonic Polypectomy: Predicting Prime Post-procedural Timing
verfasst von:
Natalia Causada Calo, Jeffrey Mosko
Erschienen in:
Digestive Diseases and Sciences
|
Ausgabe 7/2022
Einloggen, um Zugang zu erhalten
Excerpt
Colonoscopic detection and removal of adenomas reduces colorectal cancer incidence and associated mortality [
1]. Though colonoscopy is considered a safe procedure, it is associated with a risk of bleeding when polypectomy is performed. Though the risk of post-polypectomy bleeding (PPB) is 1% in patients without risk factors [
2], it is 1.8–8% in patients receiving antiplatelet or anticoagulation therapy [
3]. Other factors that can influence the risk of PPB include comorbidities such as renal and cardiovascular disease, polyp size and morphology, and polypectomy technique [
4]. For instance, in patients requiring complex resections with techniques such as wide-field endoscopic mucosal resection, the risk of bleeding was reported to be 6.2%, with repeat colonoscopy required in half of the patients [
5]. Importantly, the highest bleeding risk is present within 48 h of the initial polypectomy. …
